Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
Bo LianHua WeiRuiyan PanJingui SunBo ZhangJing-Liang WuXiujie LiGuixiang TianPublished in: International journal of nanomedicine (2021)
Gal-LPs co-loaded with chemotherapeutic and antiangiogenic drugs are a promising strategy for anti-hepatoma therapy.